New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 13, 2018 - The FDA approved an update to the Warnings and Precautions section of the Viberzi (eluxadoline) drug label regarding constipation.
Download PDF
Return to publications
